Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease

Share Article

Innovative Products from Lee Biosolutions helping save lives

News Image
Heart disease Is the leading cause of death in the US with men and women

Lee Biosolutions, a global biotech healthcare company is announcing it is increasing its investment in the development and manufacture of highly valued cardiac markers used in early detection of heart disease due to increase demand. The company’s scientific team's extensive expertise with protein chemistry has led to the development and commercialization of important cardiac biomarkers used in the industry such as CKMB, Troponin, Myoglobin, CRP, Myeloperoxidase, HDL and LDL.

According to the World Health Organization, Cardiovascular Disease (CVDs) is the number one cause of death in the world with over 17 million people dying in 2012 alone. In the United States, 1 in every 4 people will die each year from heart disease. Some say that heart disease kills more people than all the cancer victims.

Burton Lee, CEO explained, "Early detection will help save lives which is why diagnostic companies around the world seek us out because we have the scientific expertise in isolating the specific marker that they need to help in the detection of heart disease. When you go in for a blood test, its very likely the enzyme you see on your report is part of a cardiac panel in which we supplied the enzyme components. Its extremely gratifying to everyone working here that the products we produce will be used in blood test that will be saving someone’s life.”

Lee Biosolutions stands out in the clinical diagnostic industry because of its historical manufacturing experience in mammalian tissues and serum protein extraction, purification and isolation. The company can tailor the purification, development, process chromatography and protein characterization to ensure its clients obtain the right product for their final application.

About Lee Biosolutions, Inc.:
We are headquartered in a 41,000 square feet state of the art cGMP-compliant facility in Maryland Heights, MO. Lee Biosolutions is a certified, licensed ISO, FDA, EPA and USDA leader in process development and bulk manufacturing of high quality purified enzymes and related proteins for research and clinical diagnostic tests. Lee Biosolutions products are used for such pathologies as cardiovascular disease, cancer, diabetes, urine analysis, coagulation, obesity, inflammatory, neurological, autoimmune diseases and immunological disorders.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Burton Lee

Burton Lee
Visit website